861847
羰基氰化物 4-（三氟甲氧基）苯腙
97%
别名:
FCCP, 羰基氰对三氟甲氧基苯腙
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
CF3OC6H4NHN=C(CN)2
化学文摘社编号:
分子量:
254.17
EC Number:
206-730-8
UNSPSC Code:
12352103
MDL number:
Beilstein/REAXYS Number:
664446
InChI
1S/C10H5F3N4O/c11-10(12,13)18-9-3-1-7(2-4-9)16-17-8(5-14)6-15/h1-4,16H
InChI key
BMZRVOVNUMQTIN-UHFFFAOYSA-N
SMILES string
FC(F)(F)Oc1ccc(N\N=C(/C#N)C#N)cc1
assay
97%
mp
174-175 °C (dec.) (lit.)
法规信息
新产品
此项目有
Lin Du et al.
Journal of natural products, 73(11), 1868-1872 (2010-10-12)
The mammea-type coumarin mammea E/BB (1) was found to inhibit both hypoxia-induced and iron chelator-induced hypoxia-inducible factor-1 (HIF-1) activation in human breast tumor T47D cells with IC(50) values of 0.96 and 0.89 μM, respectively. Compound 1 suppressed the hypoxic induction
A Magge et al.
Journal of applied microbiology, 106(3), 814-824 (2009-02-04)
To determine roles of coats in staining Bacillus subtilis spores, and whether spores have membrane potential. Staining by four dyes and autofluorescence of B. subtilis spores that lack some (cotE, gerE) or most (cotE gerE) coat protein was measured. Wild-type
Robin K Minor et al.
Scientific reports, 1, 70-70 (2012-02-23)
Sirt1 is an NAD(+)-dependent deacetylase that extends lifespan in lower organisms and improves metabolism and delays the onset of age-related diseases in mammals. Here we show that SRT1720, a synthetic compound that was identified for its ability to activate Sirt1
Dawn A Delfín et al.
Bioorganic & medicinal chemistry, 17(2), 820-829 (2008-12-09)
BTB 06237 (2-[(2,4-dichloro-5-methylphenyl)sulfanyl]-1,3-dinitro-5-(trifluoromethyl) benzene), a compound previously identified through QSAR pharmacophore development and a virtual screen of the Maybridge database, possesses potent and selective activity against Leishmania parasites. In the present study, several analogs of BTB 06237 were synthesized and
Sean Ekins et al.
Drug metabolism and disposition: the biological fate of chemicals, 38(12), 2302-2308 (2010-09-17)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predictive in vivo, in vitro, and in silico models to identify compounds
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持